An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.

<h4>Background</h4>The artemisinin-based combination treatment (ACT) of dihydroartemisinin (DHA) and piperaquine (PQP) is a promising novel anti-malarial drug effective against multi-drug resistant falciparum malaria. The aim of this study was to show non-inferiority of DHA/PQP vs. artesunate-mefloq...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Neena Valecha, Aung Pyae Phyo, Mayfong Mayxay, Paul N Newton, Srivicha Krudsood, Sommay Keomany, Maniphone Khanthavong, Tiengkham Pongvongsa, Ronnatrai Ruangveerayuth, Chirapong Uthaisil, David Ubben, Stephan Duparc, Antonella Bacchieri, Marco Corsi, Bappanad H K Rao, Prabash C Bhattacharya, Nagesh Dubhashi, Susanta K Ghosh, Vas Dev, Ashwani Kumar, Sasithon Pukrittayakamee
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Public Library of Science (PLoS) 2010-07-01
Edice:	PLoS ONE
On-line přístup:	https://doi.org/10.1371/journal.pone.0011880
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!